Lupin, Zydus Allowed to Expand Patent Argument for Myrbetriq

Imagine a medicine called Myrbetriq that helps with a leaky bladder.

Two companies, Lupin and Zydus, are trying to make a cheaper version.

The original maker, Astellas, has a patent, like a special right to sell it.

These two companies were given the opportunity by the court to have a broader argument.

This means they can explain why they should be allowed to make the cheaper version.

The court ruled that it wants all argument scope to be given in one time.

The shares of Lupin and Zydus increased, which is good for them.

The medicine has a big market worth billions of dollars.